Quarterly sales fell to 14.4 billion Swiss francs ($15.80 billion), in line with analysts expectations, also due to a strong Swiss franc weighing on overseas revenue, the family-controlled Swiss drugmaker said in a statement.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TvqFxAc
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment